Ask A Lawyer

Tell Us Your Case Information for Fastest Lawyer Match!

Please include all relevant details from your case including where, when, and who it involoves.
Case details that can effectively describe the legal situation while also staying concise generally receive the best responses from lawyers.


By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Email, Phone, Text Messages, Terms of Use, and Privacy Policy. Information provided may not be privileged or confidential.

Fuller v. Insys Therapeutics

by Mark C. Dewland on Dec. 27, 2018

Accident & Injury Medical Malpractice 

Summary:

Ex-Insys CEO to plead guilty to opioid kickback scheme

Nate Raymond

3 Min Read

  •  
  •  

BOSTON (Reuters) - The former chief executive of Insys Therapeutics Inc (INSY.O) has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a powerful opioid medication in order to boost its sales, U.S. prosecutors said on Wednesday.

 

 

 

FILE PHOTO: A box of the Fentanyl-based drug Subsys, made by Insys Therapeutics Inc, is seen in an undated photograph provided by the U.S. Attorney's Office for the Southern District of Alabama. U.S. Attorney's Office for the Southern District of Alabama/Handout via REUTERS

 

 

Michael Babich, who resigned as the Arizona-based drugmaker’s CEO in 2015 and was due to face trial next month, has agreed to plead guilty to conspiracy and mail fraud charges, federal prosecutors in Boston disclosed in a court filing.

 

Five former Insys executives and managers indicted along with Babich, including John Kapoor, the company’s founder and former chairman, remain scheduled to go on trial in late January. They have pleaded not guilty.

The terms of Babich’s plea deal were not disclosed, and it was unclear whether he would agree to cooperate with prosecutors and testify at that trial, as has another former Insys executive who recently pleaded guilty to racketeering conspiracy.

Prosecutors requested a Jan. 9 plea hearing. A lawyer for Babich, 42, declined to comment.

The case centers on Subsys, Insys’ under-the-tongue spray for managing pain in cancer patients. It contains fentanyl, an opioid 100 times stronger than morphine.

Prosecutors allege that from 2012 to 2015, Kapoor, Babich and others conspired to bribe doctors in exchange for prescribing their patients Subsys. Prosecutors said they also defrauded insurers into paying for Subsys.

Prosecutors allege Insys paid doctors kickbacks in the form of fees to participate in speaker programs ostensibly meant to educate medical professionals about Subsys that were actually shams.

The case has been brought amid a national opioid addiction epidemic. According to the U.S. Centers for Disease Control and Prevention, opioids were involved in around 47,600 overdose deaths in 2017.

Babich, who was originally indicted in 2016, is married to a former Insys sales representative, Natalie Babich, who in 2017 pleaded guilty to conspiring to pay kickbacks and became a government witness.

Wall Street poised to drop after 1,000-point Dow gain

She testified this month at the trial of Christopher Clough, a former physician assistant in New Hampshire accused of accepting kickbacks from Insys. A federal jury in Concord, New Hampshire convicted Clough on Dec. 18.

In August, Insys said it had agreed to settle a related U.S. Justice Department probe for at least $150 million.

Reporting by Nate Raymond; editing by Alexia Garamfalvi and Rosalba O'Brien

Legal Articles Additional Disclaimer

Lawyer.com is not a law firm and does not offer legal advice. Content posted on Lawyer.com is the sole responsibility of the person from whom such content originated and is not reviewed or commented on by Lawyer.com. The application of law to any set of facts is a highly specialized skill, practiced by lawyers and often dependent on jurisdiction. Content on the site of a legal nature may or may not be accurate for a particular state or jurisdiction and may largely depend on specific circumstances surrounding individual cases, which may or may not be consistent with your circumstances or may no longer be up-to-date to the extent that laws have changed since posting. Legal articles therefore are for review as general research and for use in helping to gauge a lawyer's expertise on a matter. If you are seeking specific legal advice, Lawyer.com recommends that you contact a lawyer to review your specific issues. See Lawyer.com's full Terms of Use for more information.